Mark D Topazian MD

Advanced Endoscopic Interventional, Biliary Tract Disease, Gastrointestinal Cancer, Pancreas Disease

Professor, Internal Medicine, Mayo Medical School

Summary

Dr. Mark Topazian is a gastroenterologist in Rochester, MN. He received his medical degree from Yale School of Medicine and has been in practice 32 years. He specializes in advanced endoscopic interventional, biliary tract disease, gastrointestinal cancer, and pancreas disease and is experienced in interventional gastroenterology, biliary tract disease, pancreatitis, pancreatic disease, and esophageal stenting. Since 2019 he has spent most of each year teaching medicine in Addis Ababa, Ethiopia. He has more than 200 publications and over 10,000 citings.

University of California (San Francisco)Fellowship, Gastroenterology, 1989 - 1991
Yale-New Haven Medical CenterResidency, Internal Medicine, 1985 - 1988
Yale School of MedicineClass of 1985

PubMed

Prevalence and Patterns of Opioid Use in Chronic Pancreatitis.
Anna Evans Phillips, Darwin L Conwell, Shuang Li, Jami L Saloman, Phil A Hart
Clinical and Translational Gastroenterology. 2025-02-05
1 citations
Association of Serum Endocannabinoid Levels with Pancreatitis and Pancreatitis-Related Pain.
Marc T Goodman, Christina Lombardi, Alexa Torrens, Catherine Bresee, Jami L Saloman
Cannabis and Cannabinoid Research. 2025-02-01
1 citations
EUS for the evaluation of esophageal injury after catheter ablation for atrial fibrillation.
Karl Akiki, William B Minteer, Vinay Chandrasekhara, Tala Mahmoud, Ryan J Law
Gastrointestinal Endoscopy. 2025-02-01

Journal Articles

High-Grade Dysplasia in Resected Main-Duct Intraductal Papillary Mucinous Neoplasm (MD-IPMN) Is Associated with an Increased Risk of Subsequent Pancreatic Cancer
Thomas C Smyrk, Naoki Takahashi, Randall K Pearson, Mark D Topazian, Michael L Kendrick, Bret T Petersen, Lizhi Zhang, Ferga C Gleeson, Michael J Levy, Suresh T Chari, Nature
End-Stage Renal Disease Is Associated with Increased Post Endoscopic Retrograde Cholangiopancreatography Adverse Events in Hospitalized Patients
Michael J Levy, Fateh Bazerbachi, Won K Cho, Mark D Topazian, Bret T Petersen, World Journal of Gastroenterology

Tu1912 THE ADDITION OF A TUBULAR GASTROPLASTY EXIT TO ENDOSCOPIC TRANSORAL OUTLET REDUCTION (TUBULAR TORE) FOR MANAGEMENT OF WEIGHT REGAIN AFTER ROUX-EN-Y GASTRIC BYPASS ENHANCES OUTCOMESMay 2018
Tu1912 THE ADDITION OF A TUBULAR GASTROPLASTY EXIT TO ENDOSCOPIC TRANSORAL OUTLET REDUCTION (TUBULAR TORE) FOR MANAGEMENT OF WEIGHT REGAIN AFTER ROUX-EN-Y GASTRIC BYPASS ENHANCES OUTCOMESMay 2018

Dr. Fischer Wants to Improve the Health of Children EverywhereJuly 22nd, 2021
Large-Caliber Metal Stents Versus Plastic Stents for the Management of Pancreatic Walled-off NecrosisMay 3rd, 2020
Younger Brother’s Pancreatic Cancer Leads to Regular Screening for His Oldest BrotherJune 6th, 2019
Join now to see all